Integra Lifesciences Holdings Corp (IART)
28.41
-0.97
(-3.30%)
USD |
NASDAQ |
Apr 25, 16:00
28.42
+0.01
(+0.04%)
After-Hours: 20:00
Integra Lifesciences Holdings Revenue (TTM): 1.542B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.542B |
| September 30, 2023 | 1.543B |
| June 30, 2023 | 1.545B |
| March 31, 2023 | 1.562B |
| December 31, 2022 | 1.558B |
| September 30, 2022 | 1.565B |
| June 30, 2022 | 1.567B |
| March 31, 2022 | 1.559B |
| December 31, 2021 | 1.542B |
| September 30, 2021 | 1.526B |
| June 30, 2021 | 1.509B |
| March 31, 2021 | 1.378B |
| December 31, 2020 | 1.372B |
| September 30, 2020 | 1.378B |
| June 30, 2020 | 1.387B |
| March 31, 2020 | 1.512B |
| December 31, 2019 | 1.518B |
| September 30, 2019 | 1.506B |
| June 30, 2019 | 1.493B |
| March 31, 2019 | 1.475B |
| December 31, 2018 | 1.472B |
| September 30, 2018 | 1.458B |
| June 30, 2018 | 1.371B |
| March 31, 2018 | 1.287B |
| December 31, 2017 | 1.188B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.075B |
| June 30, 2017 | 1.047B |
| March 31, 2017 | 1.014B |
| December 31, 2016 | 992.08M |
| September 30, 2016 | 977.57M |
| June 30, 2016 | 953.61M |
| March 31, 2016 | 916.97M |
| December 31, 2015 | 882.73M |
| September 30, 2015 | 860.65M |
| June 30, 2015 | 831.80M |
| March 31, 2015 | 850.48M |
| December 31, 2014 | 863.01M |
| September 30, 2014 | 725.32M |
| June 30, 2014 | 741.04M |
| March 31, 2014 | 715.24M |
| December 31, 2013 | 696.83M |
| September 30, 2013 | 829.88M |
| June 30, 2013 | 826.72M |
| March 31, 2013 | 831.34M |
| December 31, 2012 | 830.87M |
| September 30, 2012 | 819.96M |
| June 30, 2012 | 812.06M |
| March 31, 2012 | 795.22M |
| December 31, 2011 | 780.08M |
| September 30, 2011 | 770.69M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.372B
Minimum
Dec 2020
1.567B
Maximum
Jun 2022
1.503B
Average
1.526B
Median
Sep 2021
Revenue (TTM) Benchmarks
| Stryker Corp | 20.50B |
| OraSure Technologies Inc | 405.47M |
| Insulet Corp | 1.697B |
| PROCEPT BioRobotics Corp | 136.19M |
| Perspective Therapeutics Inc | 0.00 |